214 related articles for article (PubMed ID: 15899524)
1. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis.
Szczepanik M; Tutaj M; Bryniarski K; Dittel BN
J Neuroimmunol; 2005 Jul; 164(1-2):105-14. PubMed ID: 15899524
[TBL] [Abstract][Full Text] [Related]
2. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
3. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
Tutaj M; Szczepanik M
J Autoimmun; 2007 Jun; 28(4):208-15. PubMed ID: 17442539
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice.
Santos LM; al-Sabbagh A; Londono A; Weiner HL
Cell Immunol; 1994 Sep; 157(2):439-47. PubMed ID: 7520838
[TBL] [Abstract][Full Text] [Related]
5. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
6. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
Lider O; Santos LM; Lee CS; Higgins PJ; Weiner HL
J Immunol; 1989 Feb; 142(3):748-52. PubMed ID: 2464023
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
8. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
Lange C; Doster H; Steinbach K; Kalbacher H; Scholl M; Melms A; Bischof F
Brain Behav Immun; 2009 Aug; 23(6):861-7. PubMed ID: 19362139
[TBL] [Abstract][Full Text] [Related]
10. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells.
Issazadeh S; Mustafa M; Ljungdahl A; Höjeberg B; Dagerlind A; Elde R; Olsson T
J Neurosci Res; 1995 Apr; 40(5):579-90. PubMed ID: 7602612
[TBL] [Abstract][Full Text] [Related]
12. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
Racke MK; Dhib-Jalbut S; Cannella B; Albert PS; Raine CS; McFarlin DE
J Immunol; 1991 May; 146(9):3012-7. PubMed ID: 1707929
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.
Tan LJ; Kennedy MK; Dal Canto MC; Miller SD
J Immunol; 1991 Sep; 147(6):1797-802. PubMed ID: 1716280
[TBL] [Abstract][Full Text] [Related]
15. Initiation and regulation of CNS autoimmunity.
Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis.
Benson JM; Stuckman SS; Cox KL; Wardrop RM; Gienapp IE; Cross AH; Trotter JL; Whitacre CC
J Immunol; 1999 May; 162(10):6247-54. PubMed ID: 10229871
[TBL] [Abstract][Full Text] [Related]
17. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells.
Zhang X; Reddy J; Ochi H; Frenkel D; Kuchroo VK; Weiner HL
Int Immunol; 2006 Apr; 18(4):495-503. PubMed ID: 16540527
[TBL] [Abstract][Full Text] [Related]
18. A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
Zhang GX; Yu S; Li Y; Ventura ES; Gran B; Rostami A
J Neuroimmunol; 2005 Apr; 161(1-2):101-12. PubMed ID: 15748949
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Karussis DM; Slavin S; Lehmann D; Mizrachi-Koll R; Abramsky O; Ben-Nun A
J Immunol; 1992 Mar; 148(6):1693-8. PubMed ID: 1541813
[TBL] [Abstract][Full Text] [Related]
20. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
